当前位置:首页 - 行情中心 - 皓元医药(688131) - 财务分析 - 现金流量表

皓元医药

(688131)

  

流通市值:28.65亿  总市值:49.82亿
流通股本:8648.52万   总股本:1.50亿

现金流量表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金459,234,993.51,957,974,789.091,271,700,666.86848,738,782.94
收到的税费返还6,975,502.4833,181,256.8225,158,884.4221,735,968.93
收到其他与经营活动有关的现金8,589,088.5227,476,022.2616,703,959.5612,535,916.44
经营活动现金流入的平衡项目0000
经营活动现金流入小计474,799,584.52,018,632,068.171,313,563,510.84883,010,668.31
购买商品、接受劳务支付的现金192,788,769.011,093,177,240.89765,042,769.97584,537,495.59
支付给职工以及为职工支付的现金188,365,837.8777,273,849.84563,400,791.95402,201,436.15
支付的各项税费24,421,466.7782,409,667.5662,946,271.9840,246,118.2
支付其他与经营活动有关的现金40,898,024.91129,377,488.35116,072,464.7251,039,028.29
经营活动现金流出的平衡项目0000
经营活动现金流出小计446,474,098.492,082,238,246.641,507,462,298.621,078,024,078.23
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额28,325,486.01-63,606,178.47-193,898,787.78-195,013,409.92
二、投资活动产生的现金流量:
收回投资收到的现金-927,649,445.3762,720,045.3641,630,470.47
取得投资收益收到的现金-1,341,147.961,259,027.711,046,644.15
处置固定资产、无形资产和其他长期资产收回的现金净额949,772.2558,973.121,083,138.94407,867.31
投资活动现金流入的平衡项目0000
投资活动现金流入小计949,772.2929,549,566.38765,062,211.95643,084,981.93
购建固定资产、无形资产和其他长期资产支付的现金120,462,037.34259,767,624.21228,371,028.69174,022,839.86
投资支付的现金-959,292,901.28791,363,501.28670,273,926.45
取得子公司及其他营业单位支付的现金-39,000,00039,431,813.8139,431,813.81
投资活动现金流出的平衡项目0000
投资活动现金流出小计120,462,037.341,258,060,525.491,059,166,343.78883,728,580.12
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-119,512,265.14-328,510,959.11-294,104,131.83-240,643,598.19
三、筹资活动产生的现金流量:
吸收投资收到的现金10,000,00080,134,513.1330,134,513.1324,694,513.13
其中:子公司吸收少数股东投资收到的现金10,000,00050,000,000--
取得借款收到的现金155,645,972.06735,187,466.97565,111,728.45385,124,242.55
筹资活动现金流入平衡项目0000
筹资活动现金流入小计165,645,972.06815,321,980.1595,246,241.58409,818,755.68
偿还债务支付的现金85,126,390.65295,684,948.79163,244,787.2895,352,722.22
分配股利、利润或偿付利息支付的现金6,725,881.8764,477,049.4255,231,376.3449,705,539.09
支付其他与筹资活动有关的现金13,815,104.3745,951,353.0434,699,990.326,286,367.31
筹资活动现金流出平衡项目0000
筹资活动现金流出小计105,667,376.89406,113,351.25253,176,153.92171,344,628.62
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额59,978,595.17409,208,628.85342,070,087.66238,474,127.06
四、汇率变动对现金及现金等价物的影响-425,949.693,110,971.276,707,4088,722,091.89
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-31,634,133.6520,202,462.54-139,225,423.95-188,460,789.16
加:期初现金及现金等价物余额475,465,963.61455,263,501.07455,263,592.99455,263,501.07
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额443,831,829.96475,465,963.61316,038,169.04266,802,711.91
补充资料:
净利润-126,307,603.99-93,874,503.55
资产减值准备-83,999,102.8-34,922,808.72
固定资产和投资性房地产折旧-75,002,614.58-36,540,944.76
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-75,002,614.58-36,540,944.76
无形资产摊销-8,432,010.72-4,002,837.14
长期待摊费用摊销-34,310,122.36-17,280,763.91
处置固定资产、无形资产和其他长期资产的损失--62,704.26--264,842.98
财务费用-30,349,282.03-5,927,417.44
投资损失-4,772,110.67-1,202,530.97
递延所得税--45,227,752.11--17,279,600.29
其中:递延所得税资产减少--15,081,354.02--14,353,164.29
递延所得税负债增加--30,146,398.09--2,926,436
存货的减少--317,171,975.95--317,948,259.63
经营性应收项目的减少--131,487,938.63--106,095,449.8
经营性应付项目的增加--8,415,918.49-8,619,237.99
其他-23,569,406.8-18,772,202.23
现金的期末余额-475,465,963.61-266,802,711.91
减:现金的期初余额-455,263,501.07-455,263,501.07
公告日期2024-04-302024-04-252023-10-312023-08-29
审计意见(境内)标准无保留意见
TOP↑